Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib vs Imatinib in First-Line GIST
NCT00812240Phase 3Terminated
- Sponsor
- AB Science
- Start
- Jan 2009
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of masitinib in gastrointestinal stromal tumor (GIST), sponsored by AB Science. Started Jan 2009; status: terminated.
02
Drugs
masitinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00812240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00812240.